These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5309479)

  • 1. Some studies on the selection and efficiency of live influenza vaccine viruses.
    Tyrrell DA; Beare AS
    Bull World Health Organ; 1969; 41(3):581-4. PubMed ID: 5309479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of live influenza vaccines.
    Smorodincev AA
    Bull World Health Organ; 1969; 41(3):585-8. PubMed ID: 5309480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory and clinical characteristics of attenuated strains of influenza virus.
    Maassab HF; Francis T; Davenport FM; Hennessy AV; Minuse E; Anderson G
    Bull World Health Organ; 1969; 41(3):589-94. PubMed ID: 5309481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory characteristics of attenuated influenza viruses.
    Beare AS
    Bull World Health Organ; 1969; 41(3):595-8. PubMed ID: 5309482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigetion into the attenuation of influenza viruses by serial passage.
    Beare AS; Bynoe ML; Tyrrell DA
    Br Med J; 1968 Nov; 4(5629):482-4. PubMed ID: 5697664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of influenza immunization: influence of route of administration and vaccine strain.
    Waldman RH; Bond JO; Levitt LP; Hartwig EC; Prather EC; Baratta RL; Neill JS; Small PA
    Bull World Health Organ; 1969; 41(3):543-8. PubMed ID: 4908340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desoxycholate-split influenza vaccines.
    Warburton MF
    Bull World Health Organ; 1969; 41(3):639-41. PubMed ID: 5309488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the haemagglutinin production of influenza A2 Hong Kong variant and recombinant strains.
    Tauraso NM; O'Brien TC
    Bull World Health Organ; 1970; 43(2):275-9. PubMed ID: 5312524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
    Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
    Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of influenza virus mutants for possible use in a live virus vaccine.
    Mills J; Van Kirk J; Hill DA; Chanock RM
    Bull World Health Organ; 1969; 41(3):599-606. PubMed ID: 5309483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies with live attenuated influenza vaccines.
    Douglas RG; Betts RF
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):153-8. PubMed ID: 685888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of live attenuated influenza vaccine ts-1(E) in man.
    Gwaltney JM
    Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
    Chiu SS; Feng S; Chan KH; Lo JY; Chan EL; So LY; Cowling BJ; Peiris JS
    Vaccine; 2016 Apr; 34(19):2164-9. PubMed ID: 27013437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.